title: An appraisal of methods for the analysis of longitudinal categorical data with MAR drop-outs.
abstract: A number of methods for analysing longitudinal ordinal categorical data with missing-at-random drop-outs are considered. Two are maximum-likelihood methods (MAXLIK) which employ marginal global odds ratios to model associations. The remainder use weighted or unweighted generalized estimating equations (GEE). Two of the GEE use Cholesky-decomposed standardized residuals to model the association structure, while another three extend methods developed for longitudinal binary data in which the association structures are modelled using either Gaussian estimation, multivariate normal estimating equations or conditional residuals. Simulated data sets were used to discover differences among the methods in terms of biases, variances and convergence rates when the association structure is misspecified. The methods were also applied to a real medical data set. Two of the GEE methods, referred to as Cond and ML-norm in this paper and by their originators, were found to have relatively good convergence rates and mean squared errors for all sample sizes (80, 120, 300) considered, and one more, referred to as MGEE in this paper and by its originators, worked fairly well for all but the smallest sample size, 80.
authors.affiliation: Department of Statistics and Actuarial Science, University of Waterloo, Waterloo, Ontario, Canada.
authors.forename: R J
authors.initials: RJ
authors.lastname: O'Hara Hines
authors.forename: W G S
authors.initials: WG
authors.lastname: Hines
mesh_terms: D001699:Biometry / Q000379:methods*; D003627:Data Interpretation, Statistical; D016666:Fluvoxamine / Q000627:therapeutic use; D006801:Humans; D016013:Likelihood Functions; D008137:Longitudinal Studies; D001523:Mental Disorders / Q000188:drug therapy; D015233:Models, Statistical; D016017:Odds Ratio; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use
chemical_list: D016666:Fluvoxamine; D017367:Selective Serotonin Reuptake Inhibitors